Drugs / Dypirone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT01182974 Comparator | Aug 2010 → Aug 2011 | infectious disease with sepsis | Barzilai Medical Center | Suspended | No outcome recorded Stop: Enrollment |
| — | NCT04148846 Background | Sep 2019 → Sep 2020 | headache disorder | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dypirone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01182974 ↗ |
| Route | Intramuscular | “1 gr PO/PZ/PR/IM” NCT01182974 ↗ |
| Route | Oral | “1 gr PO/PZ/PR/IM” NCT01182974 ↗ |
| Route | Rectal | “1 gr PO/PZ/PR/IM” NCT01182974 ↗ |